|
|
immune effector process
|
GO:0002252 |
321 |
0.499
|
|
|
|
non canonical wnt signaling pathway
|
GO:0035567 |
33 |
0.401
|
|
|
|
negative regulation of synaptic vesicle transport
|
GO:1902804 |
3 |
0.373
|
|
|
|
membrane fusion
|
GO:0061025 |
38 |
0.355
|
|
|
|
organelle fusion
|
GO:0048284 |
28 |
0.323
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.279
|
Human |
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.241
|
|
|
|
negative regulation of calcium ion dependent exocytosis
|
GO:0045955 |
3 |
0.224
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.224
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
61 |
0.217
|
Human |
|
|
rap protein signal transduction
|
GO:0032486 |
3 |
0.205
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.193
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.181
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.178
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.178
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.169
|
|
|
|
microtubule based movement
|
GO:0007018 |
84 |
0.168
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.163
|
|
|
|
barbed end actin filament capping
|
GO:0051016 |
6 |
0.162
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.161
|
|
|
|
wnt signaling pathway planar cell polarity pathway
|
GO:0060071 |
27 |
0.160
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.158
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.157
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.154
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.152
|
|
|
|
vacuole organization
|
GO:0007033 |
38 |
0.152
|
|
|
|
arp2 3 complex mediated actin nucleation
|
GO:0034314 |
3 |
0.151
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.150
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.149
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.145
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.143
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.141
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.139
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.135
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.134
|
|
|
|
receptor localization to synapse
|
GO:0097120 |
4 |
0.133
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.132
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.132
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.130
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.128
|
Human |
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.123
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.123
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.119
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.118
|
|
|
|
vesicle fusion
|
GO:0006906 |
16 |
0.117
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.117
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.110
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
62 |
0.110
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.108
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.107
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.106
|
|
|
|
establishment of synaptic vesicle localization
|
GO:0097480 |
57 |
0.105
|
|
|
|
synaptic vesicle localization
|
GO:0097479 |
59 |
0.104
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.103
|
|
|
|
negative regulation of exocytosis
|
GO:0045920 |
12 |
0.102
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.102
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.101
|
|
|
|
calcium ion dependent exocytosis
|
GO:0017156 |
35 |
0.101
|
|
|
|
negative regulation of actin filament depolymerization
|
GO:0030835 |
9 |
0.099
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.097
|
|
|
|
positive regulation of peptide hormone secretion
|
GO:0090277 |
31 |
0.092
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.090
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.090
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.087
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.087
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.087
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.086
|
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
45 |
0.086
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.085
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.084
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.084
|
|
|
|
synaptic vesicle transport
|
GO:0048489 |
57 |
0.083
|
|
|
|
regulation of vacuole organization
|
GO:0044088 |
4 |
0.081
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.079
|
|
|
|
regulation of lamellipodium assembly
|
GO:0010591 |
3 |
0.079
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.079
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
54 |
0.077
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.077
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.076
|
|
|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.076
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.076
|
|
|
|
positive regulation of metalloenzyme activity
|
GO:0048554 |
3 |
0.076
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.075
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.075
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.075
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.075
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.074
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.073
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.073
|
|
|
|
regulation of endocytic recycling
|
GO:2001135 |
3 |
0.072
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.071
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.069
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.067
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.066
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.066
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.066
|
Human |
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.066
|
|
|
|
positive regulation of protein autophosphorylation
|
GO:0031954 |
4 |
0.066
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.065
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.065
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.064
|
|
|
|
negative regulation of lymphocyte apoptotic process
|
GO:0070229 |
24 |
0.064
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.064
|
Human |
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.063
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.063
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.063
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.060
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.059
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.059
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.059
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.059
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.058
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.058
|
|
|
|
regulation of actin filament depolymerization
|
GO:0030834 |
13 |
0.057
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.056
|
|
|
|
negative regulation of synaptic vesicle exocytosis
|
GO:2000301 |
3 |
0.056
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.055
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.055
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.055
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.055
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.054
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.054
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.054
|
|
|
|
retrograde transport endosome to golgi
|
GO:0042147 |
2 |
0.053
|
|
|
|
actin filament depolymerization
|
GO:0030042 |
15 |
0.053
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.053
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.053
|
Human |
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.052
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.052
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.051
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.051
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.051
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.051
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.051
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.050
|
Human |
|
|
regulation of t cell mediated cytotoxicity
|
GO:0001914 |
18 |
0.050
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.050
|
|
|
|
positive regulation of neutrophil apoptotic process
|
GO:0033031 |
1 |
0.050
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.049
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.049
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.048
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.048
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.048
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.048
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.048
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.048
|
|
|
|
vesicle localization
|
GO:0051648 |
86 |
0.048
|
|
|
|
t cell mediated cytotoxicity
|
GO:0001913 |
26 |
0.048
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.048
|
|
|
|
regulation of actin filament polymerization
|
GO:0030833 |
38 |
0.048
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.047
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.047
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.047
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.047
|
Human |
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.046
|
|
|
|
regulation of calcium ion dependent exocytosis
|
GO:0017158 |
16 |
0.046
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.046
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.046
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.045
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.044
|
|
|
|
sensory perception of touch
|
GO:0050975 |
2 |
0.044
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.044
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.044
|
|
|
|
regulation of actin filament length
|
GO:0030832 |
45 |
0.043
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.043
|
|
|
|
substrate dependent cell migration cell extension
|
GO:0006930 |
4 |
0.043
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.042
|
|
|
|
negative regulation of protein depolymerization
|
GO:1901880 |
21 |
0.042
|
|
|
|
t cell apoptotic process
|
GO:0070231 |
39 |
0.042
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.042
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.042
|
|
|
|
positive regulation of insulin secretion
|
GO:0032024 |
26 |
0.042
|
|
|
|
actin cytoskeleton reorganization
|
GO:0031532 |
21 |
0.041
|
|
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.040
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.040
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.040
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.039
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.039
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.039
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.039
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.038
|
|
|
|
submandibular salivary gland formation
|
GO:0060661 |
1 |
0.038
|
|
|
|
exocyst localization
|
GO:0051601 |
2 |
0.038
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.038
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.038
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.037
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.037
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.037
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.037
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.036
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.036
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.036
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.035
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.035
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.035
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.034
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.034
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.034
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.034
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.034
|
|
|
|
negative regulation of neurotransmitter secretion
|
GO:0046929 |
5 |
0.034
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.033
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.033
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.032
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.032
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.032
|
|
|
|
positive regulation of vasculogenesis
|
GO:2001214 |
7 |
0.032
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.032
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.031
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.031
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.031
|
|
|
|
protein targeting to vacuole
|
GO:0006623 |
3 |
0.031
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.031
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
36 |
0.031
|
|
|
|
positive regulation of lamellipodium assembly
|
GO:0010592 |
2 |
0.031
|
|
|
|
substrate dependent cell migration
|
GO:0006929 |
18 |
0.030
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.030
|
|
|
|
endoplasmic reticulum tubular network organization
|
GO:0071786 |
1 |
0.030
|
|
|
|
regulation of synaptic vesicle exocytosis
|
GO:2000300 |
11 |
0.030
|
|
|
|
negative regulation of interleukin 8 secretion
|
GO:2000483 |
1 |
0.030
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.030
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.029
|
|
|
|
protein complex disassembly
|
GO:0043241 |
40 |
0.029
|
|
|
|
regulation of protein depolymerization
|
GO:1901879 |
26 |
0.029
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.029
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.029
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.029
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.029
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.029
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.029
|
|
|
|
transforming growth factor beta1 production
|
GO:0032905 |
3 |
0.028
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.028
|
|
|
|
hair follicle cell proliferation
|
GO:0071335 |
3 |
0.028
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.028
|
|
|
|
intrahepatic bile duct development
|
GO:0035622 |
2 |
0.028
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.028
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.028
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.028
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.028
|
|
|
|
adherens junction organization
|
GO:0034332 |
28 |
0.027
|
|
|
|
regulation of clathrin mediated endocytosis
|
GO:2000369 |
4 |
0.027
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.027
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.027
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.027
|
|
|
|
regulation of hair follicle cell proliferation
|
GO:0071336 |
2 |
0.027
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.027
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.027
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.027
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.026
|
|
|
|
granzyme mediated apoptotic signaling pathway
|
GO:0008626 |
1 |
0.026
|
|
|
|
maintenance of location in cell
|
GO:0051651 |
24 |
0.026
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.026
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.026
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.026
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.026
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.026
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.026
|
|
|
|
cytoskeleton dependent intracellular transport
|
GO:0030705 |
50 |
0.025
|
|
|
|
regulated secretory pathway
|
GO:0045055 |
32 |
0.025
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.025
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.025
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.025
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.025
|
|
|
|
regulation of synaptic vesicle transport
|
GO:1902803 |
13 |
0.025
|
|
|
|
pigment metabolic process
|
GO:0042440 |
32 |
0.025
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.024
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.024
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.024
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.024
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.024
|
|
|
|
microtubule based transport
|
GO:0010970 |
50 |
0.024
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.024
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.024
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.024
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.024
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.024
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.023
|
Human |
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.023
|
|
|
|
insulin secretion involved in cellular response to glucose stimulus
|
GO:0035773 |
36 |
0.023
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.023
|
|
|
|
synaptic vesicle exocytosis
|
GO:0016079 |
26 |
0.023
|
|
|
|
regulation of establishment of planar polarity
|
GO:0090175 |
28 |
0.023
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.023
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.023
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.023
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.023
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.023
|
|
|
|
protein localization to vacuole
|
GO:0072665 |
4 |
0.023
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
46 |
0.023
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.023
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.022
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.022
|
|
|
|
neutrophil degranulation
|
GO:0043312 |
6 |
0.022
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.022
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.022
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.022
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.022
|
|
|
|
negative regulation of oxidative stress induced intrinsic apoptotic signaling pathway
|
GO:1902176 |
4 |
0.022
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.022
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.022
|
|
|
|
regulation of synapse structural plasticity
|
GO:0051823 |
4 |
0.022
|
|
|
|
fatty acid derivative transport
|
GO:1901571 |
14 |
0.022
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.022
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.021
|
Human |
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.021
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.021
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.021
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.021
|
|
|
|
protein localization involved in establishment of planar polarity
|
GO:0090251 |
1 |
0.021
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.021
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.021
|
|
|
|
regulation of leukocyte mediated cytotoxicity
|
GO:0001910 |
38 |
0.021
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.021
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.020
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.020
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.020
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.020
|
|
|
|
regulation of neutrophil apoptotic process
|
GO:0033029 |
1 |
0.020
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.020
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.020
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.020
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.020
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.020
|
|
|
|
regulation of protein autophosphorylation
|
GO:0031952 |
8 |
0.020
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.020
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.019
|
|
|
|
cellular response to hexose stimulus
|
GO:0071331 |
47 |
0.019
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.019
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.019
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.019
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.019
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.019
|
|
|
|
lamellipodium organization
|
GO:0097581 |
29 |
0.019
|
|
|
|
eye pigmentation
|
GO:0048069 |
3 |
0.019
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.019
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.019
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.019
|
|
|
|
l amino acid transport
|
GO:0015807 |
32 |
0.018
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.018
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.018
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.018
|
|
|
|
virion assembly
|
GO:0019068 |
1 |
0.018
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.018
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.018
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.018
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.018
|
|
|
|
regulation of cell killing
|
GO:0031341 |
40 |
0.018
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.018
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.018
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.017
|
|
|
|
olfactory bulb interneuron differentiation
|
GO:0021889 |
12 |
0.017
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.017
|
Human |
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.017
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.017
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.017
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.017
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.017
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.017
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.017
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.017
|
|
|
|
positive regulation of lamellipodium organization
|
GO:1902745 |
3 |
0.016
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.016
|
|
|
|
neutrophil chemotaxis
|
GO:0030593 |
36 |
0.016
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.016
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.016
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.016
|
|
|
|
receptor recycling
|
GO:0001881 |
11 |
0.016
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.016
|
|
|
|
regulation of protein complex disassembly
|
GO:0043244 |
28 |
0.016
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.016
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.016
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.016
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.016
|
Human |
|
|
icosanoid secretion
|
GO:0032309 |
12 |
0.016
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.016
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.016
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.016
|
|
|
|
cell fate determination involved in pattern specification
|
GO:0060582 |
1 |
0.016
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.016
|
|
|
|
positive regulation of hair follicle cell proliferation
|
GO:0071338 |
1 |
0.015
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.015
|
|
|
|
regulation of vasculogenesis
|
GO:2001212 |
9 |
0.015
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.015
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.015
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.015
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.015
|
|
|
|
negative regulation of actin filament polymerization
|
GO:0030837 |
11 |
0.015
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.015
|
|
|
|
regulation of acute inflammatory response
|
GO:0002673 |
27 |
0.015
|
|
|
|
vacuolar transport
|
GO:0007034 |
11 |
0.015
|
|
|
|
regulation of substrate adhesion dependent cell spreading
|
GO:1900024 |
12 |
0.015
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.015
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.015
|
|
|
|
chromosome movement towards spindle pole
|
GO:0051305 |
3 |
0.015
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.015
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.015
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.015
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.015
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.015
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.015
|
|
|
|
positive regulation of tumor necrosis factor ligand superfamily member 11 production
|
GO:2000309 |
1 |
0.015
|
|
|
|
axon target recognition
|
GO:0007412 |
4 |
0.015
|
|
|
|
regulation of fibrinolysis
|
GO:0051917 |
1 |
0.015
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.015
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.015
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.015
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.015
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.015
|
|
|
|
negative regulation of intracellular transport
|
GO:0032387 |
38 |
0.015
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.015
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.015
|
|
|
|
endothelial cell development
|
GO:0001885 |
20 |
0.015
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.014
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.014
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.014
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.014
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.014
|
|
|
|
negative regulation of binding
|
GO:0051100 |
39 |
0.014
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.014
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.014
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.014
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.014
|
|
|
|
actin filament capping
|
GO:0051693 |
6 |
0.014
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.014
|
|
|
|
positive regulation of leukocyte mediated cytotoxicity
|
GO:0001912 |
31 |
0.014
|
|
|
|
protein depolymerization
|
GO:0051261 |
34 |
0.014
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.014
|
|
|
|
sperm individualization
|
GO:0007291 |
1 |
0.014
|
|
|
|
positive regulation of myeloid cell apoptotic process
|
GO:0033034 |
4 |
0.014
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.014
|
|
|
|
positive regulation of t cell mediated immunity
|
GO:0002711 |
24 |
0.014
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.014
|
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.014
|
|
|
|
phagolysosome assembly
|
GO:0001845 |
3 |
0.014
|
|
|
|
positive regulation of transforming growth factor beta1 production
|
GO:0032914 |
2 |
0.014
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.014
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
45 |
0.014
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.014
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.013
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.013
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.013
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.013
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.013
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.013
|
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
43 |
0.013
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.013
|
|
|
|
morphogenesis of an epithelial fold
|
GO:0060571 |
28 |
0.013
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.013
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.013
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.013
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.013
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.013
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.013
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.013
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.013
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.013
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.013
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.013
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.013
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.013
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.013
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.013
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.013
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.013
|
|
|
|
rab protein signal transduction
|
GO:0032482 |
1 |
0.012
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.012
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.012
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.012
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.012
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.012
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.012
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.012
|
|
|
|
positive regulation of synapse structural plasticity
|
GO:0051835 |
1 |
0.012
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.012
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.012
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.012
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.012
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.012
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.012
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.012
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.012
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.012
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.012
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.012
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.012
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.012
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.012
|
|
|
|
cellular glucose homeostasis
|
GO:0001678 |
52 |
0.012
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.012
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.012
|
|
